New trial finds first-ever Alzheimer’s drug to slow cognitive decline
A Phase 3 trial testing lecanemab recruited just under 2,000 participants in the early stages of Alzheimer’s disease
COVID raises risk of long-term brain injury, large US study finds
The year-long study, published in Nature Medicine, assessed brain health across 44 different disorders
Two or more sodas a day linked to increased risk of death from cancer
A new study has shed important new light on the relationship between sugary drinks and cancer